Biotest AG/ DE0005227201 /
8/2/2019 12:00:00 AM | Chg. - | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
22.00EUR | - | 116 Turnover: - |
-Bid Size: - | -Ask Size: - | 1.6 bill.EUR | 0.10% | - |
GlobeNewswire
12/3/2021
Marizyme Inc. Announces Results of GOAL Study Presented at 7th Annual International Coronary Congres...
GlobeNewswire
8/9/2021
ADMA Biologics Announces Commercial Availability of Expanded Vial Size Offerings for BIVIGAM® and NA...
GlobeNewswire
4/13/2021
ADMA Biologics Announces Poster Presentation Highlighting Pharmacoeconomic Burden of HIV and HBV Inf...
GlobeNewswire
12/9/2020
ADMA Biologics Enters Into $100 Million Credit Facility Loan Amendment with Perceptive Advisors
GlobeNewswire
10/10/2019
2019 Italian Molecular Diagnostic Analyzers and Reagent Forecasts for 100 Tests: Supplier Shares, Vo...
GlobeNewswire
10/10/2019
Canada Molecular Diagnostic Analyzers and Reagent Forecasts for 100 Tests: Supplier Shares and Strat...
GlobeNewswire
10/10/2019
United Arab Emirates Molecular Diagnostic Analyzers and Reagent Forecasts for 100 Tests 2019: Suppli...
GlobeNewswire
10/10/2019
Bahrain Molecular Diagnostic Analyzers and Reagent Forecasts for 100 Tests, 2019: Infectious and Gen...
GlobeNewswire
10/10/2019
Cyprus Nucleic Acid Testing Market for 100 Assays, 2019: Companies Such as Arca Biopharma, Diadexus ...
GlobeNewswire
10/10/2019
South Korean Nucleic Acid Testing Market for 100 Assays: Five-year test volume and sales forecasts
GlobeNewswire
10/10/2019
2019 Kuwait Nucleic Acid Testing Market for 100 Assays: Supplier Shares and Strategies, Country Volu...
GlobeNewswire
10/10/2019
Malta Nucleic Acid Testing Market for 100 Assays: Infectious and Genetic Diseases, Cancer, Forensic ...
GlobeNewswire
8/22/2019
ADMA Biologics Announces Commercial Relaunch and its First Commercial Sales of BIVIGAM®
GlobeNewswire
7/8/2019
ADMA Biologics Receives FDA Approval for License Transfers for BIVIGAM® and Nabi-HB®
GlobeNewswire
5/3/2019
ADMA Biologics Elects to Draw-Down $27.5 Million in Capital from Existing Perceptive Advisors Credi...